Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
5,787,579
-
Share change
-
-840,130
-
Total reported value
-
$3,799,243
-
Price per share
-
$0.49
-
Number of holders
-
35
-
Value change
-
-$772,748
-
Number of buys
-
12
-
Number of sells
-
16
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q4 2020
As of 31 Dec 2020,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,787,579 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GSA CAPITAL PARTNERS LLP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, Qube Research & Technologies Ltd, MORGAN STANLEY, UBS Group AG, and Verdence Capital Advisors LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.